Evercore Wealth Management’s iBio IBIO Stock Holding History

Evercore Wealth Management’s Portfolio IBIO Stock Details IBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-6	Closed	-$21K	–	1015
2014 Q4	$21K	Buy	+6	New	+$32K	﹤0.01%	662

Other funds holding IBIO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

PAMG

Patton Albertson Miller Group Chattanooga, Tennessee $1B AUM 40.9% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Evercore Wealth Management's IBIO Position: Q1 2015 in Review

Evercore Wealth Management sold out of iBio (IBIO) in Q1 2015, closing a stake of 6 shares — an estimated $21K sold.

Evercore Wealth Management first reported a position in IBIO in Q4 2014 and held it in 1 quarter. The position peaked at $21K in Q4 2014. 16 funds tracked by Wall St. Rank hold IBIO as of Q1 2015.

Evercore Wealth Management reported no remaining iBio position as of Q1 2015 after selling out during the quarter.
Evercore Wealth Management sold 6 iBio shares in Q1 2015, an estimated $21K.
Evercore Wealth Management first reported a position in iBio in Q4 2014 and held it in 1 quarter.
Evercore Wealth Management's iBio position peaked at $21K in Q4 2014.
16 funds tracked by Wall St. Rank held iBio as of Q1 2015.

Based on Evercore Wealth Management's 13F filing for Q1 2015, filed 6 May 2015.